BRAVO 3: Bivalirudin No Better Than Heparin in TAVRBRAVO 3: Bivalirudin No Better Than Heparin in TAVR

In BRAVO 3, the use of bivalirudin yielded no benefit over unfractionated heparin, which experts say should limit its use to a small segment of patients, such as those with heparin-induced thrombocytopenia. Heartwire from Medscape
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news